Failure of cidofovir in HIV-associated multicentric Castleman disease
- 1 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (11), 4368-4369
- https://doi.org/10.1182/blood-2004-01-0158
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatmentBlood, 2004
- High incidence of Kaposi sarcoma–associated herpesvirus–related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman diseaseBlood, 2002
- Long-term remission of Kaposi sarcoma–associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapyBlood, 2001
- Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi’s sarcoma progression in two patients with AIDSAIDS, 2001
- High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patientsBlood, 2000
- Differential Viral Protein Expression in Kaposi's Sarcoma-Associated Herpesvirus-Infected DiseasesThe American Journal of Pathology, 2000
- Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir ImplantNew England Journal of Medicine, 1999
- Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.JCI Insight, 1997
- Exacerbations of Clinical Symptoms in Human Immunodeficiency Virus Typ 1-Infected Patients with Multicentric Castleman's Disease Are Associated with a High Increase in Kaposi's Sarcoma Herpesvirus DNA Load in Peripheral Blood Mononuclear CellsThe Journal of Infectious Diseases, 1997
- Multicentric Castlemanʼs disease in HIV infectionAIDS, 1996